Background
Methods
Lung cancer cell lines
Tumor samples
Clinical Parameters | Cases n (%) | |
---|---|---|
Age
| ≥65 | 28 (51.9%) |
<65 | 26 (48.1%) | |
Gender
| Male | 37 (68.5%) |
Female | 17 (31.5%) | |
Smoking history
| Yes | 46 (85%) |
No | 6 (11%) | |
Unknown | 2 (3%) | |
Karnosfsky
| ≥80 | 45 (83.3%) |
<80 | 9 (16.7%) | |
Histology
| Squamous Cell Carcinoma | 21 (38.5%) |
Adenocarcinoma | 32 (59.6%) | |
Large Cell Carcinoma | 1 (1.9%) | |
Differentation grade
| Good differentiated | 11 (20.4%) |
Moderate | 16 (29.6%) | |
Poor | 27 (50%) | |
Stage
| I-II | 22 (40.7%) |
III | 18 (33.3%) | |
IV | 14 (26%) | |
Local/Advanced
| Local (stage I II) | 22 (40.7%) |
Advanced (stage III-IV) | 32 (59.3%) | |
Progression
| Yes | 26 (48.1%) |
No | 28 (51.9%) | |
Death
| Yes | 25 (46.3%) |
No | 29 (53.7%) |
DNA extraction
Methylation-Specific Multiplex Ligation-Dependent Probe Amplification (MS-MLPA)
Gene | Namea | Probes | Functional implications | Chromosomal Localizationb |
---|---|---|---|---|
PRDM2
| PR domain containing 2, with ZNF domain | 09146-L02862 | Cell cycle control | 1p36 |
RUNX3
| Runt-related transcription factor 3 | 11131-L03905 | TGFB signaling | 1p36 |
RARB
| Retinoic acid receptor beta | 10362-L10900 | Cell differentiation and proliferation | 3p24 |
HLTF
| Helicase-like transcription factor | 09152-L09384(probe 1) 02758-L02207(probe 2) | Transcription regulation | 3q25.1-q26.1 |
SCGB3A1
| Secretoglobin, family 3A, member 1 | 03305-L09382 (probe1) 11132-L12956(probe 2) | Cell differentiation and proliferation | 5q35-qter |
ID4
| Inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 04497-L03909(probe 1) 04496-L03908(probe 2) | Transcription regulation | 6p22.3 |
TWIST1
| Twist homolog 1 (Drosophila) | 02080-L02886 | Cell differentiation and proliferation | 7p21 |
SFRP4
| Secreted frizzled-related protein 4 | 03744-L03204(probe 1) 09147-L03205(probe 2) | WNT antagonism | 7p14.1 |
DLC1
| Deleted in liver cancer 1 | 02754-L02203(probe 1) 02753-L02202(probe 2) | Cell differentiation and proliferation | 8p22 |
SFRP5
| Secreted frizzled-related protein 5 | 09149-L03207(probe 1) 09148-L12957(probe 2) | WNT antagonism | 10q24 |
BNIP3
| BCL2/adenovirus E1B 19kDa Interacting protein 3 | 07138-L12958 | Proliferation and apoptosis | 10q.26.3 |
H2AFX
| H2A histone family, member X | 08511-L08607(probe 1) 08509-L08605(probe 2) | Transcription regulation | 11q23.3 |
CCND2
| Cyclin D2 | 03313-L02668(probe 1) 03312-L09381(probe 2) | Cell cycle control | 12p13 |
CACNA1G
| Calcium channel, voltage-dependent, T type, alpha 1G subunit | 10123-L10466 | Cell differentiation and proliferation | 17q22 |
TGIF
| TGFB-induced factor homebox 1 | 02850-L13256 | TGFB signaling | 18p11.31 |
BCL2
| B-cell CLL/lymphoma2 | 10352-L10890 | Proliferation and apoptosis | 18q21.3 |
CACNA1A
| Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 09055-L09224 | Cell differentiation and proliferation | 19p13 |
TIMP3
| TIMP metallopeptidase inhibitor 3 | 10357-L10895(probe 1) 10354-L10892(probe 2) | Invasion and metastasis | 22q12.3 |
Statistical Analysis
Results
Quality assessment of MS-MLPA assay
MS-MLPA profiles of lung cancer cell lines
MS-MLPA profiles for clinico-histopathologic stratification of lung tumors
Gene | Overall (%) | Histology (%) | Differentation Grade (%) | Tumor stage (%) | ||||
---|---|---|---|---|---|---|---|---|
Methylation n = 54 | SCC n = 21 | ADC n = 32 | Good n = 11 | Moderate n = 16 | Poor n = 27 | Local n = 22 | Advanced n = 32 | |
PRDM2
| 22 (40.7) | 10 (45.4) | 12 (37.5) | 21 (45.6) | 0 (0) | 12 (44.4) | 10 (45.4) | 12 (37.5) |
RUNX3
| 23 (42.5) | 13 (59.1) | 10 (31.2) | 19 (41.3) | 2 (33.3) | 10 (37.0) | 13 (59.1) | 10 (31.2) |
RARB
| 20 (37) | 8 (36.4) | 12 (37.5) | 17 (36.9) | 3 (50.0) | 10 (37.0) | 8 (36.4) | 12 (37.5) |
HLTF
| 8 (14.8) | 1 (4.5) | 7 (21.9) | 8 (17.4) | 0 (0) | 7 (25.9) | 1 (4.5) | 7 (21.9) |
HLT-2
| 17 (31.5) | 9 (40.9) | 8 (25.0) | 14 (30.4) | 2 (33.3) | 10 (37.0) | 9 (40.9) | 8 (25.0) |
SCGB3A1
| 27 (50.0) | 15 (68.2) | 12 (37.5) | 24 (52.2) | 2 (33.3) | 15 (55.5) | 15 (68.2) | 12 (37.5) |
SCGB3A1-2
| 17 (31.5) | 12 (54.5) | 5 (15.6) | 12 (26.0) | 4 (66.7) | 9 (33.3) | 12 (54.5) | 5 (15.6) |
ID4
| 25 (46.3) | 12 (54.5) | 13 (40.6) | 23 (50.0) | 1 (1.7) | 12 (44.4) | 12 (54.5) | 13 (40.6) |
ID4-2
| 11 (20.4) | 5 (22.7) | 6 (18.7) | 10 (21.7) | 1 (1.7) | 7 (25.9) | 5 (22.7) | 6 (18.7) |
TWIST1
| 21 (38.9) | 9 (40.9) | 12 (37.5) | 19 (41.3) | 2 (33.3) | 10 (37.0) | 9 (40.9) | 12 (37.5) |
SFRP4
| 10 (18.5) | 7 (31.8) | 3 (9.4) | 9 (19.5) | 1 (1.7) | 5 (18.5) | 7 (31.8) | 3 (9.4) |
SFRP4-2
| 16 (29.6) | 11 (50.0) | 5 (15.6) | 12 (26.0) | 3 (50.0) | 8 (29.6) | 11 (50.0) | 5 (15.6) |
DLC1
| 22 (40.7) | 12 (54.5) | 10 (31.2) | 18 (39.1) | 3 (50.0) | 13 (48.1) | 12 (54.5) | 10 (31.2) |
DLC1-2
| 27 (50.0) | 15 (68.2) | 12 (37.5) | 21 (45.6) | 5 (83.3) | 14 (51.8) | 15 (68.2) | 12 (37.5) |
SFRP5
| 17 (31.5) | 8 (36.4) | 9 (28.1) | 15 (32.6) | 2 (33.3) | 10 (37.0) | 8 (36.4) | 9 (28.1) |
SFRP5-2
| 12 (22.2) | 6 (27.3) | 6 (18.7) | 9 (19.6) | 2 (33.3) | 8 (29.6) | 6 (27.3) | 6 (18.7) |
BNIP3
| 24 (44.4) | 12 (54.5) | 12 (37.5) | 20 (43.5) | 2 (33.3) | 13 (48.1) | 12 (54.5) | 12 (37.5) |
H2AFX
| 10 (18.5) | 5 (22.7) | 5 (15.6) | 9 (19.5) | 1 (1.7) | 6 (22.2) | 5 (22.7) | 5 (15.6) |
H2AFX-2
| 9 (16.7) | 6 (27.3) | 3 (9.4) | 8 (17.4) | 1 (1.7) | 5 (18.5) | 6 (27.3) | 3 (9.4) |
CCND2
| 26 (48.1) | 13 (59.1) | 13 (40.6) | 22 (47.8) | 3 (50.0) | 15 (55.5) | 13 (59.1) | 13 (40.6) |
CCND2-2
| 29 (53.7) | 14 (63.6) | 15 (46.9) | 25 (54.3) | 4 (66.7) | 15 (55.5) | 14 (63.6) | 15 (46.9) |
CACNA1G
| 21 (38.9) | 12 (54.5) | 9 (28.1) | 19 (41.3) | 1 (1.7) | 12 (44.4) | 12 (54.5) | 9 (28.1) |
TGIF
| 10 (18.5) | 5 (22.7) | 5 (15.6) | 9 (19.5) | 1 (1.7) | 6 (22.2) | 5 (22.7) | 5 (15.6) |
BCL2
| 8 (14.8) | 4 (18.2) | 4 (12.5) | 8 (17.4) | 0 (0) | 5 (18.5) | 4 (18.2) | 4 (12.5) |
CACNA1A
| 18 (33.3) | 11 (50.0) | 7 (21.9) | 13 (28.3) | 4 (66.7) | 8 (29.6) | 11 (50.0) | 7 (21.9) |
TIMP3
| 10 (18.5) | 7 (31.8) | 3 (9.4) | 9 (19.6) | 1 (1.7) | 5 (18.5) | 7 (31.8) | 3 (9.4) |
TIMP3-2
| 11 (20.4) | 7 (31.8) | 4 (12.5) | 9 (19.6) | 1 (1.7) | 6 (22.2) | 7 (31.8) | 4 (12.5) |